Basis: latest reported fiscal quarter. Source: stored company filings; unavailable inputs remain N/A.
The latest quarterly total equity is $1.67B with QoQ Growth of (1.02%). Total equity, also called shareholders' equity, is assets minus liabilities. The book value in P/B is the part attributable to common shareholders: total equity minus preferred stock.
Reported quarterly total equity; no daily interpolation. Q2 FY2026 (2026-06-30): $1.67B.
FMP quote market capitalization / book value attributable to common shareholders (matching reported total stockholders equity minus preferred stock) Quote observation: 2026-10-06T20:43:04.494Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
| Period | Total Equity | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-30 | $1.67B | (1.02%) | (4.44%) |
| Q1 FY2026Period end 2026-03-31 | $1.69B | (1.45%) | (3.01%) |
| Q4 FY2025Period end 2025-12-31 | $1.71B | (0.96%) | (4.29%) |
| Q3 FY2025Period end 2025-09-30 | $1.73B | (1.08%) | (8.81%) |
| Q2 FY2025Period end 2025-06-30 | $1.75B | +0.45% | (10.45%) |
| Q1 FY2025Period end 2025-03-31 | $1.74B | (2.75%) | (11.53%) |
| Q4 FY2024Period end 2024-12-31 | $1.79B | (5.63%) | (9.94%) |
| Q3 FY2024Period end 2024-09-30 | $1.90B | (2.86%) | (5.39%) |
| Q2 FY2024Period end 2024-06-30 | $1.95B | (0.76%) | (3.26%) |
| Q1 FY2024Period end 2024-03-31 | $1.97B | (1.00%) | +0.27% |
| Q4 FY2023Period end 2023-12-31 | $1.99B | (0.87%) | (0.55%) |
| Q3 FY2023Period end 2023-09-30 | $2.00B | (0.67%) | +70.91% |
| Q2 FY2023Period end 2023-06-30 | $2.02B | +2.86% | +74.72% |
| Q1 FY2023Period end 2023-03-31 | $1.96B | (1.81%) | +69.01% |
| Q4 FY2022Period end 2022-12-31 | $2.00B | +70.36% | +83.49% |
| Q3 FY2022Period end 2022-09-30 | $1.17B | +1.54% | +55.08% |
| Q2 FY2022Period end 2022-06-30 | $1.16B | (0.50%) | +50.97% |
| Q1 FY2022Period end 2022-03-31 | $1.16B | +6.60% | +49.56% |
| Q4 FY2021Period end 2021-12-31 | $1.09B | +43.99% | +97.96% |
| Q3 FY2021Period end 2021-09-30 | $756.30M | (1.15%) | +43.95% |
| Q2 FY2021Period end 2021-06-30 | $765.10M | (1.43%) | +23.68% |
| Q1 FY2021Period end 2021-03-31 | $776.20M | +41.10% | +21.05% |
| Q4 FY2020Period end 2020-12-31 | $550.10M | +4.70% | (20.48%) |
| Q3 FY2020Period end 2020-09-30 | $525.40M | (15.07%) | +59.84% |
| Q2 FY2020Period end 2020-06-30 | $618.60M | (3.52%) | +72.46% |
| Q1 FY2020Period end 2020-03-31 | $641.20M | (7.31%) | +63.82% |
| Q4 FY2019Period end 2019-12-31 | $691.80M | +110.47% | +70.97% |
| Q3 FY2019Period end 2019-09-30 | $328.70M | (8.36%) | (64.35%) |
| Q2 FY2019Period end 2019-06-30 | $358.70M | (8.35%) | (61.87%) |
| Q1 FY2019Period end 2019-03-31 | $391.40M | (3.27%) | (37.94%) |
| Q4 FY2018Period end 2018-12-31 | $404.64M | (56.11%) | (38.20%) |
| Q3 FY2018Period end 2018-09-30 | $921.97M | (1.99%) | (9.81%) |
| Q2 FY2018Period end 2018-06-30 | $940.70M | +49.16% | N/A |
| Q1 FY2018Period end 2018-03-31 | $630.66M | (3.68%) | N/A |
| Q4 FY2017Period end 2017-12-31 | $654.73M | (35.95%) | N/A |
| Q3 FY2017Period end 2017-09-30 | $1.02B | N/A | N/A |
| Q2 FY2017Period end 2017-06-30 | $6.25M | N/A | N/A |
| Q1 FY2017Period end 2017-03-31 | $8.20M | N/A | N/A |
| Q4 FY2016Period end 2016-12-31 | $9.68M | N/A | N/A |
| Q3 FY2016Period end 2016-09-30 | ($8.33M) | N/A | +97.00% |
| Q2 FY2016Period end 2016-06-30 | ($6.63M) | N/A | +97.58% |
| Q1 FY2016Period end 2016-03-31 | ($9.89M) | N/A | +96.34% |
| Q4 FY2015Period end 2015-12-31 | ($4.03M) | +98.55% | +98.47% |
| Q3 FY2015Period end 2015-09-30 | ($277.44M) | (1.50%) | N/A |
| Q2 FY2015Period end 2015-06-30 | ($273.33M) | (1.31%) | N/A |
| Q1 FY2015Period end 2015-03-31 | ($269.81M) | (2.17%) | N/A |
| Q4 FY2014Period end 2014-12-31 | ($264.08M) | N/A | N/A |
| Q1 FY2014Period end 2014-03-31 | ($14.38M) | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
